Michael Reiter, DO
Diagnostic Radiology · Stony Brook, NYNPI 1598960916
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $173,600 of the $173,736 with a category attached, or 99.9%. Pfizer accounts for 98.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $61,340 and has fallen 99.8% since, to $136 in 2024. Among diagnostic radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $3048.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$172K
- Merck$2K
- Astellas Pharma Inc$170
- Heartflow, Inc.$136
Across 275 payments — averaging $1514.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- EMD Serono, Inc.$99K
- AbbVie$92K
- Takeda Pharmaceuticals U.S.A., Inc.$83K
- Astrazeneca UK Limited$72K
- Regeneron$37K
- Beigene (suzhou) Co., Ltd.$15K
- plus $20K from 4 others
What the payments were for
- Consulting fees$173,600100%
- Food & beverage$1360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 54 | $171,830 |
| Merck | 1 | $1,600 |
| Astellas Pharma Inc | 1 | $170 |
| Heartflow, Inc. | 1 | $136 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$173,736 in reported general payments places this provider in the 95th percentile of 2,530 diagnostic radiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Stony Brook
- Kevin BakerStony Brook$447K
- Steven WestStony Brook$226K
- Lev BangiyevStony Brook$121K
- Thomas SosNew York$3.5M
- Derace SchafferRochester$2.1M
- Lawrence TanenbaumNew York$1.5M
- Alan BrookBronx$930K
- Jason DunleavyWilliamsville$560K
- Gregory SicaNew York$496K
- Marc BrownNew York$435K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.